02.04.2014 18:00:00
|
Italian Branch of Global Pharma Leader Deploys Cegedim Relationship Management’s OneKey Database to Optimize Targeting Strategies
Cegedim Relationship Management today announced that Novartis Farma has implemented OneKey to maximize its wide-ranging commercial activity in Italy. As the industry’s most comprehensive, freshly-updated, and compliant healthcare professional (HCP) and organization database, OneKey provides Novartis Farma with a clear understanding of Italy’s local and regional healthcare structure. Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines, over-the-counter and animal health products.
Next Generation Database Provides New Value and Stakeholder
Intelligence in Italian Market
Cegedim Relationship
Management’s OneKey includes 13.7 million registered HCPs worldwide –
each aggregated by affiliation, specialty and organization. Novartis
Farma can benefit from OneKey’s rich capability to seamlessly adapt to
Italy’s data privacy laws – expertly ensuring continued compliance.
Further, OneKey features the most superior data quality via systematic
phone validation, real time updates, consistent database cleansing, and
constant inflow of new customer information.
Novartis Farma decided to expand their existing relationship with Cegedim because of Cegedim’s proven expertise in Italy; along with the exceptional breadth and quality of OneKey, acknowledging the database’s flexibility, as it easily integrates with their current CRM system. Novartis Farma’s OneKey subscription level includes Market Access data and Master Data Management (MDM) services to consolidate disparate data sources.
"OneKey allows Novartis Farma to strengthen CRM efficiency with the optimal coverage of registered HCPs – consistently updated by our in-house database specialists,” explained Stefan Janssens, President EMEA & APAC, Cegedim Relationship Management. "OneKey was specifically designed to help our customers generate new intelligence on their target markets and stakeholder networks, leveraging full compliance and transparency in database management. We’re proud that we can now count Novartis Farma among our many OneKey customers.”
About Cegedim Relationship Management: |
Cegedim Relationship Management is the Life Sciences industry’s leading provider of Customer Relationship Management (CRM) solutions. Designed specifically for Life Sciences, the company’s innovative business solutions incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Relationship Management enables approximately 200,000 users in many of the world’s most innovative companies to stay ahead of market challenges. In addition to CRM, Cegedim Relationship Management also provides marketing, data optimization and regulatory compliance solutions in more than 80 countries. Cegedim Relationship Management is part of the France-based Cegedim S.A. Group.
www.CegedimRM.com. Follow Cegedim Relationship Management on LinkedIn and Twitter. |
|
About Cegedim: |
Founded in 1969, Cegedim is a global technology and services company
specializing in the healthcare field. Cegedim supplies services,
technological tools, specialized software, data flow management
services and databases. Its offerings are targeted notably at
healthcare industries, life sciences companies, healthcare
professionals and insurance companies. The world leader in life
sciences CRM, Cegedim is also one of the leading suppliers of
strategic healthcare industry data. Cegedim employs 8,000 people in
more than 80 countries and generated revenue of €902 million in
2013. Cegedim SA is listed in Paris (EURONEXT: CGM).
And follow Cegedim on Twitter: @CegedimGroup. |
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cegedim S.A.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Cegedim S.A.mehr Analysen
Aktien in diesem Artikel
Cegedim S.A. | 11,75 | -10,98% |
Börse aktuell - Live Ticker
Asiens Börsen mehrheitlich im MinusDie Börsen in Fernost notieren zur Wochenmitte überwiegend in Rot.